UCSF Helen Diller Family Comprehensive Cancer Center
member announcement 10/18/2019
[ view online ]

Benioff Initiative for Prostate Cancer Research Award in Basic Science


Through a generous philanthropic gift, we are soliciting applications for funding research to understand the basic biological drivers of aggressive prostate cancer. Over the next five years, the Benioff Initiative for Prostate Cancer Research aims to accelerate prostate cancer research at UCSF. This funding is intended to support basic and translational research projects focused on the biology, detection or treatment of aggressive prostate cancer.

Applications in any aspect of basic research directly related to prostate cancer will be considered. Proposals must include how you will evaluate project milestones, provide specific metrics that can be used to evaluate outcomes. Metrics outlined in the proposal should apply to evaluations at both 6 and 12 month periods.


This RFA is open to any UCSF researchers with faculty status.

Award Amount and Terms

Awards of $75,000 - $150,000 are for one year and consideration for renewal is based on productivity. Budget proposals should not include indirect costs. Salary support for PIs should not be included in the budget. All awardees are required to submit a 6 months progress report and a final report tied to the milestones set forth in the RFA. Potential for project renewal will be weighted towards projects that meet metrics established in the proposal at reach review period.

Review Criteria

Proposals will be evaluated based on the quality of the proposed scientific methodology and potential impact. Applications not meeting the specified subject of the RFA will be rejected without review. Valid applications will be peer reviewed.

Deadline: November 29, 2019, at 5:00 pm [download RFA and cover sheet]
Contact: Nicholas Larocque, nicholas.larocque@ucsf.edu

**Please share this RFA with colleagues who may be interested.**

Request for Diversity Steering Committee Volunteers

The Cancer Center's Office of Education & Training is looking for volunteers for our Diversity Steering Committee. The committee meets 2-3 times a year and helps us set our priorities and guide our strategy for our URM programs and resources. If interested in participating, please email Jennifer Seuferer (jennifer.seuferer@ucsf.edu).

Request for Collaborating Partners in Response to Patient Engagement in Cancer Genomic Sequencing RFA

NCI has released an RFA due October 30 for Patient Engagement in Cancer Genomic Sequencing (PE-CGS) research centers. Specifically, the RFA targets highly lethal cancers; cancers with significant disparities in incidence or outcome; and cancers in understudied populations.

Mount Sinai, a member of the INSIGHT CRN, is taking the lead in responding to this RFA. In brief, the purpose of the proposal is to develop strategies to recruit patients of non-European ancestry for cancer genomic research in order to better understand the genomic architecture of risk and response to therapy in these populations using hepatocellular carcinoma (HCC) as the model system. HCC is highly lethal and is about twice as common in Asians, African-Americans, and Hispanics as in European-Americans. It is associated with Hepatitis B/C, obesity, metabolic syndrome, NASH, and specific exposures, but virtually nothing is known about the genetics of HCC in different ethnicities or in the context of different nongenetic risk factors. If successful, the expectation is that their results will provide a model for recruiting these patients for cancer research nationally. The aim is to recruit 500-1000 HCC patients of each racial ethnic group (European, African-American, Hispanic, and Asian) over the course of 5 years.

The Mount Sinai team is looking for clinical partners caring for over 50 new HCC patients annually, as well as sites to help build robust patient and community centered strategies to identify, recruit, communicate, and engage patients with HCC. These groups will work to develop culturally tailored, multi-lingual, low-literacy approaches to engage patients to recruit for genomic analyses and return of results. This will include building a robust portal for patients to obtain relevant information for them, their caregivers and their community.

> View details and requirements to participate
> If interested, please reply to Madelaine Faulkner (madelaine.faulkner@ucsf.edu) by October 23rd

Featured Funding Opportunities

  • Nov 8: Emerson Collective Cancer Research RFA
    The Emerson Collective Cancer Research Fund is requesting individual or team proposals for research projects related, but not limited to, immunotherapy, metabolic therapies, early detection advancements, 'high risk/high reward' initiatives and/or -omic approaches to cancer and drug development. Positive criteria include the potential of a project to significantly impact our understanding of and/or approaches to the prevention, diagnosis, or treatment of cancer.
  • Nov 12: AACR-Conquer Cancer Foundation of ASCO Young Investigator Award for Translational Cancer Research
    Provides funding to promising investigators to encourage and promote quality research in clinical oncology. The purpose of this jointly-supported award is to fund a physician-scientist during the transition from a fellowship program to a faculty appointment. Research projects are restricted to translational cancer research.
  • Nov 18: American Cancer Society (ACS) Individual Research Award
    Funded by the American Cancer Society, this program provides seed funding (up to $30,000) to encourage junior investigators to initiate promising new projects in cancer-related research that may enable them to compete successfully for national research grants.

More RFAs of Interest to Cancer Center Members

The following NIH/NCI funding opportunities directly align with HDFCCC goals. If you are interested in applying and receiving grant writing support, please contact Erin Bank.

View more funding opportunities

UCSF-HDFCCC Erin Hayes, Communications
415.476.5445 (voice) | communications@cc.ucsf.edu